Alpha Tau Medical Ltd.

NASDAQ:DRTS

3.1 (USD) • At close December 31, 2024
Bedrijfsnaam Alpha Tau Medical Ltd.
Symbool DRTS
Munteenheid USD
Prijs 3.1
Beurswaarde 216,765,020
Dividendpercentage 0%
52-weken bereik 1.75 - 3.4
Industrie Biotechnology
Sector Healthcare
CEO Mr. Uzi Sofer
Website https://www.alphatau.com

Over Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical

Vergelijkbare Aandelen

Day One Biopharmaceuticals, Inc. logo

Day One Biopharmaceuticals, Inc.

DAWN

12.67 USD

CareMax, Inc. logo

CareMax, Inc.

CMAX

0.422 USD

Rallybio Corporation logo

Rallybio Corporation

RLYB

0.96 USD

Bionano Genomics, Inc. logo

Bionano Genomics, Inc.

BNGO

0.288 USD

Praxis Precision Medicines, Inc. logo

Praxis Precision Medicines, Inc.

PRAX

76.96 USD

Adicet Bio, Inc. logo

Adicet Bio, Inc.

ACET

0.962 USD

Vera Therapeutics, Inc. logo

Vera Therapeutics, Inc.

VERA

42.29 USD

908 Devices Inc. logo

908 Devices Inc.

MASS

2.2 USD

Vaxart, Inc. logo

Vaxart, Inc.

VXRT

0.662 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)